Dr. Jack O. Gladstein

Dr. Peter Rowe is a Professor of Pediatrics at the Johns Hopkins University School of Medicine. He is the inaugural Sunshine Natural Wellbeing Foundation Professor of Chronic Fatigue and Related Disorders and serves as the Director of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Related Disorders Program at Johns Hopkins Children’s Center. His areas of clinical expertise include chronic fatigue syndrome and other disorders characterized by fatigue and orthostatic intolerance. Dr. Rowe and his colleagues were the first to describe the relationship between myalgic ecephalomyelitis/chronic fatigue syndrome (ME/CFS) and treatable orthostatic intolerance syndromes, as well as the association between Ehlers-Danlos syndrome and ME/CFS. After receiving his undergraduate degree from the University of Toronto, Dr. Rowe earned his medical degree at McMaster University Medical School in Ontario. He completed his residency in pediatrics at Johns Hopkins and completed his fellowship in General Pediatric Academic Development. He was on the staff at the Children's Hospital of Eastern Ontario from 1987-1991 before returning to Johns Hopkins in 1991. Dr. Rowe’s research focuses on the physiologic factors (circulatory dysregulation, allergic disorders, joint laxity, biomechanical strain, and neuroanatomic problems) that contribute to chronic fatigue as asymptom, and to ME/CFS and long COVID as conditions. In 2014, Dr. Rowe received the research award from the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME) for his clinical and scientific work on chronic fatigue syndrome and related disorders. He is a member of the research advisory council for Solve ME/CFS. He is also a member of the American Pediatric Society, the Society for Pediatric Research, the Canadian Pediatric Society, and the American Academy of Pediatrics. Dr. Rowe is rated as an Advanced provider by MediFind in the treatment of Ehlers-Danlos Syndrome (EDS). His top areas of expertise are Ehlers-Danlos Syndrome (EDS), Musculocontractural Ehlers-Danlos Syndrome (mcEDS), Pelvic Congestion Syndrome, and Vascular Ehlers-Danlos Syndrome (VEDS).

Natasha Shur is a Medical Genetics specialist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Shur is rated as an Advanced provider by MediFind in the treatment of Ehlers-Danlos Syndrome (EDS). Her top areas of expertise are Pyruvate Carboxylase Deficiency, Phenylketonuria (PKU), Ehlers-Danlos Syndrome (EDS), and Lowe Syndrome.

Dr. Joann Bodurtha is a professor of genetic medicine, pediatrics, and oncology at the Johns Hopkins University School of Medicine. Dr. Bodurtha is co-director of the regional genetics network NYMAC, co-director of the Biological Mechanisms theme in the Genes to Society Curriculum, co-director of the BIRCWH Advisory Board, Physician Advisor for the Dept. of Genetic Medicine, a member of the Advisory Committee of the JH-NHGRI Genetic Counseling program, and a member of the Johns Hopkins Medicine Institutional Review Board. She has appointments in the School of Public Health and School of Nursing. Her research focuses on risk communication and interdisciplinary genetic education. Prior to joining Johns Hopkins, Dr. Bodurtha was a professor of human and molecular genetics at VCU, where she had faculty appointments in the Departments of Pediatrics, Obstetrics-Gynecology, and Preventive Medicine and Community Health. She received her B.A. from Swarthmore College and her M.D. and M.P.H. with honors from Yale. After a year of research at the Nagasaki University School of Medicine as a Luce Scholar, she completed her residency in pediatrics at Children’s Hospital of Philadelphia and worked as a USPHS physician on the Turtle Mountain Chippewa Reservation in North Dakota. She completed her medical genetics fellowship at Virginia Commonwealth University (VCU) in 1987. Dr. Bodurtha joined the Johns Hopkins faculty in 2011. At VCU, Dr. Bodurtha helped start the Masters in Genetic Counseling program in 1990 and the Va-LEND (Leadership Education in Neurodevelopmental Disabilities) program in 1995. She served on the American Academy of Pediatrics Committee on Native American Child Health for ten years. She was the Richmond YMCA Woman of the Year in Science and Medicine in 1997. She received the VCU School of Medicine first Innovation in Teaching Award in 1999, the SCHEV Outstanding Faculty Award in 2006, the Genetic Alliance Art of Listening Award in 2008, the AUCD Professional Achievement Award in 2009, and the VCU WISDM Professional Achievement Award in 2010. A member of the Leadership Metro Richmond Class of 2000, she served as president of the WISDM (Women in Science, Dentistry, and Medicine) organization at VCU from 2000 to 2003. She has written more than 150 scientific articles, book chapters, and reviews and supervised more than 100 graduate students. She is committed to improving access to genetic services and helping make all communities be more welcoming. Dr. Bodurtha is rated as an Experienced provider by MediFind in the treatment of Ehlers-Danlos Syndrome (EDS). Her top areas of expertise are Ehlers-Danlos Syndrome (EDS), Micrognathia, Inborn Renal Aminoaciduria, and Blepharophimosis.